이상반응 보고
| VAERS ID | 1662598 |
|---|---|
| 성별 | 남성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | JANSSEN |
| 로트 번호 | |
| 예방접종 횟수 | |
| 접종일 | |
| 발병일 | 2021-07-28 |
| 상태 |
증상
- 코로나 바이러스 감염증 -19 : 코로나 19(COVID-19)
- 예방접종 실패(Vaccination failure)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
SARS-COV-2 INFECTION; VACCINATION FAILURE; This spontaneous report received from a physician by a Regulatory authority (EMEA EVHUMAN NLP, AT-BASGAGES-2021-041609) on 24-AUG-2021 was received on 24-AUG-2021 and concerned a 25 year old male.
The patient's height, and weight were not reported.
No past medical history or concurrent conditions were reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, route of admin not reported, batch number: XD974 expiry: UNKNOWN) dose was not reported, 1 total, administered on 17-JUN-2021 for prophylactic vaccination.
No concomitant medications were reported.
On 28-JUL-2021, the patient experienced sars-cov-2 infection (vaccination failure).
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
The outcome of the sars-cov-2 infection and vaccination failure was not reported.
This report was serious (Other Medically Important Condition).
This report was associated with product quality complaint.